You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (26)

Journals (0)

1-10 of 26 results for adjusted indirect treatment comparison

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Azithromycin or erythromycin? Macrolides for non-cystic fibrosis bronchiectasis in adults: A systematic review and adjusted indirect treatment comparison

Open access

Research article

First published 2019

Azithromycin or erythromycin? Macrolides for non-cystic fibrosis bronchiectasis in adults: A systematic review and adjusted indirect treatment comparison

Wen Li, Zhong Qin, Jie Gao [...]

Chronic Respiratory Disease

Select article: Quality of life with ribociclib versus abemaciclib as first-line treatment of HR+/HER2− advanced breast cancer: a matching-adjusted indirect comparison

Open access

Research article

First published 2023

Quality of life with ribociclib versus abemaciclib as first-line treatment of HR+/HER2− advanced breast cancer: a matching-adjusted indirect comparison

Hope S. Rugo, Victoria Harmer, Joyce O’Shaughnessy [...]

Therapeutic Advances in Medical Oncology

Select article: Population-adjusted indirect treatment comparison of maintenance PARP inhibitor with or without bevacizumab versus bevacizumab alone in women with newly diagnosed advanced ovarian cancer

Open access

Research article

First published 2021

Population-adjusted indirect treatment comparison of maintenance PARP inhibitor with or without bevacizumab versus bevacizumab alone in women with newly diagnosed advanced ovarian cancer

Robert Hettle, Charles McCrea, Chee Khoon Lee [...]

Therapeutic Advances in Medical Oncology

Select article: Matching-adjusted indirect comparison of PFS and OS comparing ribociclib plus letrozole versus palbociclib plus letrozole as first-line treatment of HR+/HER2− advanced breast cancer

Open access

Research article

First published 2023

Matching-adjusted indirect comparison of PFS and OS comparing ribociclib plus letrozole versus palbociclib plus letrozole as first-line treatment of HR+/HER2− advanced breast cancer

Komal Jhaveri, Joyce O’Shaughnessy, Peter A. Fasching [...]

Therapeutic Advances in Medical Oncology

Select article: A Matching-Adjusted Indirect Comparison (MAIC) of Centanafadine versus Methylphenidate Hydrochloride in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD): Short-Term Safety and Efficacy Outcomes: Comparaison indirecte ajustée par appariement (MAIC) entre centanafadine et le chlorhydrate de méthylphénidate chez les adultes atteints d’un trouble déficitaire de l'attention avec ou sans hyperactivité (TDAH) : Résultats en matière d’innocuité et d’efficacité à court terme

Open access

Research article

First published 2025-8

A Matching-Adjusted Indirect Comparison (MAIC) of Centanafadine versus Methylphenidate Hydrochloride in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD): Short-Term Safety and Efficacy Outcomes: Comparaison indirecte ajustée par appariement (MAIC) entre centanafadine et le chlorhydrate de méthylphénidate chez les adultes atteints d’un trouble déficitaire de l'attention avec ou sans hyperactivité (TDAH) : Résultats en matière d’innocuité et d’efficacité à court terme

Jeff Schein, Maryaline Catillon, Chunyi Xu [...]

The Canadian Journal of Psychiatry

Select article: Comment on ‘Population-adjusted indirect treatment comparison of maintenance PARP inhibitor with or without bevacizumab versus bevacizumab alone in women with newly diagnosed advanced ovarian cancer’. ( Ther Adv Med Oncol . 2021 Sep 30;13:17588359211049639)

Open access

Letter

First published 2023

Comment on ‘Population-adjusted indirect treatment comparison of maintenance PARP inhibitor with or without bevacizumab versus bevacizumab alone in women with newly diagnosed advanced ovarian cancer’. ( Ther Adv Med Oncol . 2021 Sep 30;13:17588359211049639)

Hidekatsu Nakai, Noriomi Matsumura

Therapeutic Advances in Medical Oncology

Select article: Methods for Population-Adjusted Indirect Comparisons in Health Technology Appraisal

Open access

Research article

First published 2018-2

Methods for Population-Adjusted Indirect Comparisons in Health Technology Appraisal

David M. Phillippo, Anthony E. Ades, Sofia Dias [...]

Medical Decision Making

Select article: Author response to ‘Comment on “Population-adjusted indirect treatment comparison of maintenance PARP inhibitor with or without bevacizumab versus bevacizumab alone in women with newly diagnosed advanced ovarian cancer” ( Ther Adv Med Oncol . 2021 Sep 30;13:17588359211049639)’

Open access

Letter

First published 2023

Author response to ‘Comment on “Population-adjusted indirect treatment comparison of maintenance PARP inhibitor with or without bevacizumab versus bevacizumab alone in women with newly diagnosed advanced ovarian cancer” ( Ther Adv Med Oncol . 2021 Sep 30;13:17588359211049639)’

Robert Hettle, Charles McCrea

Therapeutic Advances in Medical Oncology

Select article: Analysis of adaptive platform trials using a network approach

Open access

Research article

First published 2022-10

Analysis of adaptive platform trials using a network approach

Ian C Marschner, I Manjula Schou

Clinical Trials

Select article: Comparison of Methods for Estimating Therapy Effects by Indirect Comparisons: A Simulation Study

Retricted access

Research article

First published 2020-7

Comparison of Methods for Estimating Therapy Effects by Indirect Comparisons: A Simulation Study

Dorothea Weber, Katrin Jensen, Meinhard Kieser

Medical Decision Making

1
2
3
10 / page

Article type

Publication date

Subjects

Access